SMO and melanoma: We have previously demonstrated that melanoma migration and invasion can be impaired by siRNA targeting Hh pathway components: siRNA treatment targeting SMO and GLI1 was effective and proved to reduce migration and invasion in two different melanoma cell lines, SK-MEL-28 and A375.